Viewing Study NCT03682120

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:23 AM
Ignite Modification Date: 2026-02-25 @ 4:37 PM
Study NCT ID: NCT03682120
Status: COMPLETED
Last Update Posted: 2021-05-17
First Post: 2018-09-20
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Safety/Efficacy Study of Seqirus A/H7N9 IIV With or Without MF59(R) Adjuvant to Prevent Avian Influenza
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Avian Influenza View
None Influenza Immunisation View
Keywords:

Keywords

Keyword Brief Keyword Text View
None A/H7N9 View
None Healthy Adults View
None Immunogenicity View
None Influenza vaccine View
None MF59(R) adjuvant View
None Reactogenicity View
None Safety View